{"id":28609,"date":"2025-08-01T08:21:00","date_gmt":"2025-08-01T08:21:00","guid":{"rendered":"https:\/\/progyny.com\/?p=28609"},"modified":"2025-08-21T16:54:55","modified_gmt":"2025-08-21T16:54:55","slug":"two-fda-panels-two-very-different-approaches-to-womens-health","status":"publish","type":"post","link":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/","title":{"rendered":"Two FDA Panels, Two Very Different Approaches to Women&#8217;s Health\u00a0"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><em><em>By Janet Choi, MD, MSCP, Chief Medical Officer<\/em><\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In the past few weeks, two important FDA panels met and took very different approaches to women&#8217;s health issues. These meetings sparked a larger conversation about how medical treatments for women are evaluated and discussed.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Panel 1: Menopausal Hormone Therapy (MHT)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">On July 17, 2025, the FDA&nbsp;convened <a>an<\/a>&nbsp;<a href=\"https:\/\/www.youtube.com\/live\/_2ZRlOivC5M\">expert panel<\/a>&nbsp;during which participants called for <em>removing <\/em>strict warning labels (known as black box warnings) on certain forms of MHT, citing that many women may shy away from using MHT to treat vasomotor symptoms and prevent bone loss due to fear instilled by the labelling.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">While MHT can be effective in treating vasomotor symptoms as well as preventing bone loss, it does carry a small increased risk for blood clot and stroke\u2014though this risk does not appear to be as great for those using vaginal estrogen (which is often prescribed to treat genitourinary syndrome of menopause).&nbsp;It\u2019s important that prescribing physicians consider each patient\u2019s history, conditions, and needs in tandem with the available research on all forms of MHT and their proven benefits and risks.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Panel 2: Antidepressants During Pregnancy<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Just a few days later, on July 21, an <a href=\"https:\/\/www.youtube.com\/live\/2Nha1Zh63SA\">FDA panel<\/a>, which met on selective serotonin reuptake inhibitors (SSRIs) and Pregnancy, took a different approach. Its members argued for <em>adding <\/em>warnings about use of SSRIs\u2014oral drugs that are frequently used to treat depression and anxiety\u2014during pregnancy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This recommendation is concerning for the <a href=\"https:\/\/www.mmhla.org\/articles\/maternal-mental-health-conditions-and-statistics\">more than 20% of pregnant women who are affected by mental health disorders<\/a>. Mental health remains the leading cause of death in pregnant women and new mothers in the U.S. For most pregnant women with anxiety and depression, the benefits of stabilizing their disorders far outweigh the risks of SSRIs, and the medical community\u2019s response was swift and critical to that end. The American College of Obstetricians and Gynecologists (ACOG) <a href=\"https:\/\/www.acog.org\/news\/news-releases\/2025\/07\/statement-on-benefit-of-access-to-ssris-during-pregnancy\">emphasized<\/a> that \u201crobust evidence shows SSRIs are safe in pregnancy\u201d while &#8220;untreated depression can put patients at risk for substance use, preterm birth, preeclampsia, and limited medical care engagement.\u201d<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What This Means<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Both hormone therapy during menopause and antidepressants during pregnancy carry manageable risks, but also significant benefits. Women deserve evidence-based, balanced assessments that consider both their wellbeing and potential risks.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It\u2019s critical to demand comprehensive risk-benefit discussions in shared decision-making about treatment. The science supports thoughtful, individualized care that prioritizes what\u2019s truly best for each person\u2019s health.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Janet Choi, MD, MSCP, Chief Medical Officer In the past few weeks, two important FDA panels met and took [&hellip;]<\/p>\n","protected":false},"author":45,"featured_media":28610,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[440,576,575,609,577,586,581,579,587,578,593],"tags":[408,613,273],"class_list":["post-28609","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-consultants","category-employers","category-expert-perspectives","category-health-plans","category-individual","category-maternity-care","category-menopause-care","category-symptom-management","category-topics","category-womens-health","tag-fda","tag-menopausal-hormone-therapy","tag-pregnancy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Two FDA Panels, Two Very Different Approaches to Women&#039;s Health\u00a0 | Progyny<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Two FDA Panels, Two Very Different Approaches to Women&#039;s Health\u00a0 | Progyny\" \/>\n<meta property=\"og:description\" content=\"By Janet Choi, MD, MSCP, Chief Medical Officer In the past few weeks, two important FDA panels met and took [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Progyny\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Progyny\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-01T08:21:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-21T16:54:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/progyny.com\/wp-content\/uploads\/2025\/07\/medical-reviewer.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"768\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mae Fang\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Progyny\" \/>\n<meta name=\"twitter:site\" content=\"@Progyny\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mae Fang\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/\"},\"author\":{\"name\":\"Mae Fang\",\"@id\":\"https:\\\/\\\/progyny.com\\\/#\\\/schema\\\/person\\\/0524236fcb8c1766b65ca3e2df5dce28\"},\"headline\":\"Two FDA Panels, Two Very Different Approaches to Women&#8217;s Health\u00a0\",\"datePublished\":\"2025-08-01T08:21:00+00:00\",\"dateModified\":\"2025-08-21T16:54:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/\"},\"wordCount\":418,\"publisher\":{\"@id\":\"https:\\\/\\\/progyny.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/progyny.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/medical-reviewer.jpg\",\"keywords\":[\"FDA\",\"menopausal hormone therapy\",\"pregnancy\"],\"articleSection\":[\"Blog\",\"Consultants\",\"Employers\",\"Expert perspectives\",\"Health Plans\",\"Individual\",\"Maternity care\",\"Menopause care\",\"Symptom management\",\"Topics\",\"Women's health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/\",\"url\":\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/\",\"name\":\"Two FDA Panels, Two Very Different Approaches to Women's Health\u00a0 | Progyny\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/progyny.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/progyny.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/medical-reviewer.jpg\",\"datePublished\":\"2025-08-01T08:21:00+00:00\",\"dateModified\":\"2025-08-21T16:54:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/#primaryimage\",\"url\":\"https:\\\/\\\/progyny.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/medical-reviewer.jpg\",\"contentUrl\":\"https:\\\/\\\/progyny.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/medical-reviewer.jpg\",\"width\":768,\"height\":400,\"caption\":\"medical reviewer writing\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/progyny.com\\\/blog\\\/two-fda-panels-two-very-different-approaches-to-womens-health\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/progyny.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Two FDA Panels, Two Very Different Approaches to Women&#8217;s Health\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/progyny.com\\\/#website\",\"url\":\"https:\\\/\\\/progyny.com\\\/\",\"name\":\"Progyny\",\"description\":\"Smarter benefits for life&#039;s milestones\",\"publisher\":{\"@id\":\"https:\\\/\\\/progyny.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/progyny.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/progyny.com\\\/#organization\",\"name\":\"Progyny\",\"url\":\"https:\\\/\\\/progyny.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/progyny.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/progyny.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Progyny-Logo-no-tag-Blue-1.png\",\"contentUrl\":\"https:\\\/\\\/progyny.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Progyny-Logo-no-tag-Blue-1.png\",\"width\":925,\"height\":300,\"caption\":\"Progyny\"},\"image\":{\"@id\":\"https:\\\/\\\/progyny.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Progyny\\\/\",\"https:\\\/\\\/x.com\\\/Progyny\",\"https:\\\/\\\/www.instagram.com\\\/progynyinc\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/progyny\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/progyny.com\\\/#\\\/schema\\\/person\\\/0524236fcb8c1766b65ca3e2df5dce28\",\"name\":\"Mae Fang\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b2b74e416599ee96cd4c99adecb3b5376a0da15696fa59d178fa404ed8ba945c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b2b74e416599ee96cd4c99adecb3b5376a0da15696fa59d178fa404ed8ba945c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b2b74e416599ee96cd4c99adecb3b5376a0da15696fa59d178fa404ed8ba945c?s=96&d=mm&r=g\",\"caption\":\"Mae Fang\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Two FDA Panels, Two Very Different Approaches to Women's Health\u00a0 | Progyny","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/","og_locale":"en_US","og_type":"article","og_title":"Two FDA Panels, Two Very Different Approaches to Women's Health\u00a0 | Progyny","og_description":"By Janet Choi, MD, MSCP, Chief Medical Officer In the past few weeks, two important FDA panels met and took [&hellip;]","og_url":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/","og_site_name":"Progyny","article_publisher":"https:\/\/www.facebook.com\/Progyny\/","article_published_time":"2025-08-01T08:21:00+00:00","article_modified_time":"2025-08-21T16:54:55+00:00","og_image":[{"width":768,"height":400,"url":"https:\/\/progyny.com\/wp-content\/uploads\/2025\/07\/medical-reviewer.jpg","type":"image\/jpeg"}],"author":"Mae Fang","twitter_card":"summary_large_image","twitter_creator":"@Progyny","twitter_site":"@Progyny","twitter_misc":{"Written by":"Mae Fang","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/#article","isPartOf":{"@id":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/"},"author":{"name":"Mae Fang","@id":"https:\/\/progyny.com\/#\/schema\/person\/0524236fcb8c1766b65ca3e2df5dce28"},"headline":"Two FDA Panels, Two Very Different Approaches to Women&#8217;s Health\u00a0","datePublished":"2025-08-01T08:21:00+00:00","dateModified":"2025-08-21T16:54:55+00:00","mainEntityOfPage":{"@id":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/"},"wordCount":418,"publisher":{"@id":"https:\/\/progyny.com\/#organization"},"image":{"@id":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/#primaryimage"},"thumbnailUrl":"https:\/\/progyny.com\/wp-content\/uploads\/2025\/07\/medical-reviewer.jpg","keywords":["FDA","menopausal hormone therapy","pregnancy"],"articleSection":["Blog","Consultants","Employers","Expert perspectives","Health Plans","Individual","Maternity care","Menopause care","Symptom management","Topics","Women's health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/","url":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/","name":"Two FDA Panels, Two Very Different Approaches to Women's Health\u00a0 | Progyny","isPartOf":{"@id":"https:\/\/progyny.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/#primaryimage"},"image":{"@id":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/#primaryimage"},"thumbnailUrl":"https:\/\/progyny.com\/wp-content\/uploads\/2025\/07\/medical-reviewer.jpg","datePublished":"2025-08-01T08:21:00+00:00","dateModified":"2025-08-21T16:54:55+00:00","breadcrumb":{"@id":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/#primaryimage","url":"https:\/\/progyny.com\/wp-content\/uploads\/2025\/07\/medical-reviewer.jpg","contentUrl":"https:\/\/progyny.com\/wp-content\/uploads\/2025\/07\/medical-reviewer.jpg","width":768,"height":400,"caption":"medical reviewer writing"},{"@type":"BreadcrumbList","@id":"https:\/\/progyny.com\/blog\/two-fda-panels-two-very-different-approaches-to-womens-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/progyny.com\/"},{"@type":"ListItem","position":2,"name":"Two FDA Panels, Two Very Different Approaches to Women&#8217;s Health\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/progyny.com\/#website","url":"https:\/\/progyny.com\/","name":"Progyny","description":"Smarter benefits for life&#039;s milestones","publisher":{"@id":"https:\/\/progyny.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/progyny.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/progyny.com\/#organization","name":"Progyny","url":"https:\/\/progyny.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/progyny.com\/#\/schema\/logo\/image\/","url":"https:\/\/progyny.com\/wp-content\/uploads\/2024\/08\/Progyny-Logo-no-tag-Blue-1.png","contentUrl":"https:\/\/progyny.com\/wp-content\/uploads\/2024\/08\/Progyny-Logo-no-tag-Blue-1.png","width":925,"height":300,"caption":"Progyny"},"image":{"@id":"https:\/\/progyny.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Progyny\/","https:\/\/x.com\/Progyny","https:\/\/www.instagram.com\/progynyinc\/","https:\/\/www.linkedin.com\/company\/progyny"]},{"@type":"Person","@id":"https:\/\/progyny.com\/#\/schema\/person\/0524236fcb8c1766b65ca3e2df5dce28","name":"Mae Fang","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b2b74e416599ee96cd4c99adecb3b5376a0da15696fa59d178fa404ed8ba945c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b2b74e416599ee96cd4c99adecb3b5376a0da15696fa59d178fa404ed8ba945c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b2b74e416599ee96cd4c99adecb3b5376a0da15696fa59d178fa404ed8ba945c?s=96&d=mm&r=g","caption":"Mae Fang"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/progyny.com\/wp-json\/wp\/v2\/posts\/28609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/progyny.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/progyny.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/progyny.com\/wp-json\/wp\/v2\/users\/45"}],"replies":[{"embeddable":true,"href":"https:\/\/progyny.com\/wp-json\/wp\/v2\/comments?post=28609"}],"version-history":[{"count":0,"href":"https:\/\/progyny.com\/wp-json\/wp\/v2\/posts\/28609\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/progyny.com\/wp-json\/wp\/v2\/media\/28610"}],"wp:attachment":[{"href":"https:\/\/progyny.com\/wp-json\/wp\/v2\/media?parent=28609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/progyny.com\/wp-json\/wp\/v2\/categories?post=28609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/progyny.com\/wp-json\/wp\/v2\/tags?post=28609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}